Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
Journal of Clinical Oncology.
Times cited: 168
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
Times cited: 260